Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health problems news

Show

From To
D:A:D study: long-term treatment with tenofovir associated with increased risk of serious liver disease

Long-term therapy with the antiretroviral drug tenofovir increases the risk of end-stage liver disease and liver cancer, according to data from the D:A:D study published

Published
21 January 2016
By
Michael Carter
Electrocautery ablation only partially effective as a treatment for high-grade pre-cancerous anal lesions in HIV-positive gay men

Electrocautery ablation is only partially effective as a treatment for high-grade pre-cancerous anal lesions in HIV-positive gay men and has a high regression rate, investigators

Published
20 January 2016
By
Michael Carter
High rates of cervical disease and low rates of screening among women with HIV in Denmark

Women with HIV have a higher incidence of cervical dysplasia – pre-cancerous cell changes – compared to women of a similar age in the general

Published
19 January 2016
By
Michael Carter
High rates of modifiable cancer risk factors present in Western HIV-positive patients

The prevalence of potentially modifiable risk factors for some cancers is “extraordinarily high” among people with HIV, according to results of a meta-analysis published in

Published
18 January 2016
By
Michael Carter
High prevalence of anal infection with high-risk HPV types among HIV-positive women in France

A large proportion of women living with HIV in a national study have an anal infection with types of human papillomavirus (HPV) associated with a

Published
15 January 2016
By
Michael Carter
Viread (Tenofovir, TDF) Linked With Liver Disease and Cancer

Long-term use of Viread (tenofovir disoproxil fumarate, or TDF) is associated with an increased risk of end-stage liver disease (ESLD) as well as hepatocellular carcinoma (HCC, the most common form of liver cancer) among people with HIV.

Published
14 January 2016
From
Poz
Middle-aged people living with HIV have an increased risk of frailty

Middle-aged people living with HIV have an increased risk of frailty compared with their peers without the virus, Dutch investigators report in AIDS. The association

Published
13 January 2016
By
Michael Carter
US: Racial disparity lies at intersection of HIV, Hodgkin lymphoma

Among HIV-positive patients with Hodgkin lymphoma, a new study finds that blacks are significantly less likely than whites to receive treatment for the cancer, even though chemotherapy saves lives.

Published
12 January 2016
From
Eurekalert Medicine & Health
Hepatitis C virus linked to increased risk of Parkinson's disease, studies show

People with hepatitis C virus (HCV) infection may be more likely to develop Parkinson's disease, especially when combined with other risk factors, though the reason for the

Published
11 January 2016
By
Liz Highleyman
Malawian study provides strong evidence that HIV infection is an important risk factor for stroke

HIV infection is an important risk factor for stroke among adults in Malawi, investigators report in Neurology. The case-controlled study showed that the association between HIV and stroke

Published
05 January 2016
By
Michael Carter

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.